comparemela.com

Latest Breaking News On - Ipn fr - Page 1 : comparemela.com

Merrimack Pharmaceuticals to Hold Meeting on Corporate Dissolution

By Denny Jacob Merrimack Pharmaceuticals plans to hold a special shareholder meeting to approve a plan for a corporate dissolution. The biopharmaceutical.

Denny jacobDrug administrationMerrimack pharmaceuticalsArticle normalCancer drugsHealthcare life sciencesSpecialized drugs medicationsRegulation government policyNew products servicesProduct service approvalsCorporate industrial newsProducts servicesContent typesFactiva filtersC amp ampe industry news filterIpn fr

Ipsen Shares Fall After Forecast of Lower Margin

By Adria Calatayud Ipsen shares fell after the French pharmaceutical company forecast lower profitability this year as it expects extra.

Adria calatayudArticle normalHealthcare life sciencesFinancial performanceSales figuresEarnings projectionsShare price movement disruptionsCorporate industrial newsEquity marketsCommodity financial market newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filterIpn frFr ipn

Ipsen Reports Positive Results in Late-Stage Trial of Cancer Drug Cabometyx

By Helena Smolak Ipsen's phase-three trial of prostate cancer drug Cabometyx yielded positive results, the company said late Monday. The French.

San franciscoUnited statesHelena smolakChristelle huguetAmerican societyClinical oncology genitourinary symposiumArticle normalCancer drugsHealthcare life sciencesSpecialized drugs medicationsNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingPolitical general news

Ipsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Finds

By David Sachs A drug to treat chronic liver disease developed by Ipsen and Genfit has gained a positive result in its phase-three trial, the companies said..

David sachsNew england journalArticle normalHealthcare life sciencesNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingContent typesFactiva filtersC amp ampe industry news filterIpn frFr ipnGnft frNew products

Exelixis, Ipsen Say Prostate Cancer Phase 3 Trial Met One of Two Main Goals

By Adria Calatayud Exelixis and Ipsen said a phase 3 clinical trial evaluating a combination of drugs cabozantinib and atezolizumab in metastatic.

France generalUnited statesAdria calatayudRoche holdingArticle normalBiotechnology servicesHealthcare life sciencesNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingPolitical general newsDemographic healthMedical conditionsWomen amp 39s health

vimarsana © 2020. All Rights Reserved.